|Bid||3.0500 x 1400|
|Ask||3.0800 x 29200|
|Day's Range||2.9700 - 3.1450|
|52 Week Range||2.2000 - 10.6400|
|Beta (5Y Monthly)||3.08|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canadian cannabis company Aurora Cannabis (NASDAQ: ACB) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (NASDAQ: CGC) and Sundial Growers (NASDAQ: SNDL) are benefiting as well -- up 8.5% and 5.9%, respectively. Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.
With me today are CEO, Miguel Martin; and CFO, Glen Ibbott. Listeners are also reminded that certain matters discussed in today's conference call could constitute forward-looking statements that are subject to risks and uncertainties related to our future financial or business performance.
Aurora Cannabis Inc. reported several impairment charges and a more than $1-billion net loss in its most recent quarter Thursday as it revealed plans to close several facilities and cope with pricing pressures that ate into revenues already hampered by the COVID-19 pandemic. The third-quarter loss the Edmonton-based cannabis business reported was up from a more than $160 million loss in the same quarter last year and was coupled with $741.7 million in goodwill impairment charges and $176.1 milli